☆ 4.7 Article

The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection

ANTIVIRAL RESEARCH (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cell Biology

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

William A. Fischer et al.

Summary: In a clinical trial, the safety, tolerability, and antiviral efficacy of molnupiravir were evaluated in unvaccinated individuals with confirmed SARS-CoV-2 infection. The study found that participants receiving high-dose molnupiravir had a shorter time to viral RNA clearance and a lower detection rate of infectious virus. Molnupiravir was well tolerated across all doses.

SCIENCE TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Microbiology

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2

Wendy P. Painter et al.

Summary: Molnupiravir showed rapid appearance and dose-proportional increase in plasma, with good tolerability in healthy volunteers. The study evaluated single and multiple doses of molnupiravir and the impact of food on pharmacokinetics in subjects, showing no accumulation following multiple doses and a decrease in absorption rate when administered with food, but no decrease in overall exposure.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template

Calvin J. Gordon et al.

Summary: The study found that Molnupiravir or NHC can increase the mutation frequencies in replicating coronaviruses, leading to enhanced antiviral effects; NHC-TP primarily competes with CTP for incorporation, resulting in RNA mutations; Biochemical data support a mechanism of action of Molnupiravir that is primarily based on RNA mutagenesis mediated via the template strand.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

The need for a new strategy for Ebola vaccination

Daniel G. Bausch

Summary: The outbreaks of Ebola virus disease in the Democratic Republic of the Congo and Republic of Guinea, amidst the COVID-19 pandemic, highlight the necessity for a revision in vaccination strategies in the area.

NATURE MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye H. Khoo et al.

Summary: The study found that molnupiravir is safe and well tolerated in treating early COVID-19 patients. A dose of 800mg twice daily for 5 days was recommended for Phase II evaluation.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks

Alpha Kabinet Keita et al.

Summary: The 2021 Ebola virus outbreak in Guinea was found to be a resurgence from the previous outbreak, rather than a new spillover event from an animal reservoir. This highlights the need for long-term medical and social care for survivors to reduce the risk of re-emergence and prevent further stigmatization.

NATURE (2021)

添加到收藏夹

Article Cell Biology

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection

George R. Painter et al.

ANTIVIRAL RESEARCH (2019)

添加到收藏夹

Article Virology

Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance

Maria L. Agostini et al.

JOURNAL OF VIROLOGY (2019)

添加到收藏夹

Article Cell Biology

Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia

Mart Toots et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Sabue Mulangu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Immunology

Ebola Virus Infection Associated with Transmission from Survivors

Saskia Den Boon et al.

EMERGING INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Virology

β-D-N4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome

Nadya Urakova et al.

JOURNAL OF VIROLOGY (2018)

添加到收藏夹

Article Microbiology

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses

Jeong-Joong Yoon et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

添加到收藏夹

Article Immunology

Ebola Virus Infection in Commonly Used Laboratory Mouse Strains

Elaine Haddock et al.

JOURNAL OF INFECTIOUS DISEASES (2018)

添加到收藏夹

Article Immunology

Ebola Virus Shedding and Transmission: Review of Current Evidence

Pauline Vetter et al.

JOURNAL OF INFECTIOUS DISEASES (2016)

添加到收藏夹

Editorial Material Infectious Diseases

Ebola PHEIC is over but emergency continues

[Anonymous]

LANCET INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Virology

Validation of the Filovirus Plaque Assay for Use in Preclinical Studies

Amy C. Shurtleff et al.

VIRUSES-BASEL (2016)

添加到收藏夹

Article Virology

Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication

Olivier Reynard et al.

VIRUSES-BASEL (2015)

添加到收藏夹

Review Public, Environmental & Occupational Health

Transmission of Ebola Virus Disease: An Overview

Suresh Rewar et al.

ANNALS OF GLOBAL HEALTH (2014)

添加到收藏夹

Article Immunology

Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever

Mark G. Kortepeter et al.

JOURNAL OF INFECTIOUS DISEASES (2011)

添加到收藏夹

Article Medicine, General & Internal

Ebola haemorrhagic fever

Heinz Feldmann et al.

LANCET (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.